Akụkọ ụlọ ọrụ
-
Kedu etuto ndị thalidomide dị irè n'ịgwọ!
Thalidomide dị irè n'ịgwọ etuto ndị a! 1. Na nke siri ike etuto nwere ike iji thalidomide. 1.1. ọrịa cancer akpa ume. 1.2. Ọrịa prostate. 1.3. nodal rectal cancer. 1.4. hepatocellular carcinoma. 1.5. Ọrịa kansa afọ. ...GỤKWUO -
Apixaban na Rivaroxaban
N'ime afọ ndị na-adịbeghị anya, ahịa nke apixaban amụbawo ngwa ngwa, na ahịa ụwa agafeelarị rivaroxaban. N'ihi na Eliquis (apixaban) nwere uru karịa warfarin na igbochi ọrịa strok na ọbara ọgbụgba, na Xarelto (Rivaroxaban) na-egosi na ọ bụghị ala. Na mgbakwunye, Apixaban anaghị ...GỤKWUO -
Obeticolic acid
Na June 29, Intercept Pharmaceuticals kwupụtara na ọ natala ngwa ọgwụ ọhụrụ zuru oke site na US FDA gbasara FXR agonist obeticholic acid (OCA) maka fibrosis nke steatohepatitis na-abụghị mmanya kpatara (NASH) leta nzaghachi (CRL). FDA kwuru na CRL nke dabere na data ...GỤKWUO -
Remdesivir
Na Ọktọba 22, n'oge ọwụwa anyanwụ, US FDA kwadoro ọgwụ mgbochi nke Gilied Veklury (remdesivir) maka ojiji na ndị okenye gbara afọ 12 gbagoro ma tụọ opekata mpe 40 n'arọ nke chọrọ ụlọ ọgwụ na ọgwụgwọ COVID-19. Dabere na FDA, Veklury bụ ugbu a naanị FDA kwadoro COVID-19 t…GỤKWUO -
Nkwupụta nkwado maka Calcium Rosuvastatin
N'oge na-adịbeghị anya, Nantong Chanyoo emeela ihe ịrịba ama ọzọ na akụkọ ihe mere eme! Site na mbọ a gbara ihe karịrị otu afọ, KDMF mbụ nke Chanyoo enwetala nkwado nke MFDS. Dị ka onye na-emepụta Calcium Rosuvastatin na China, anyị chọrọ imepe isi ọhụrụ na ahịa Korea. Na ngwaahịa ndị ọzọ ga-...GỤKWUO -
Kedu ka Fette Compacting China si akwado ọgụ megide COVID-19
Ọrịa na-efe efe zuru ụwa ọnụ nke COVID-19 agbanweela elekwasị anya na mgbochi ọrịa na ịchịkwa ọrịa na mpaghara ụwa niile. Òtù WHO adịghị etinye mgbalị ọ bụla iji kpọọ mba nile ka ha wusie ịdị n'otu na imekọ ihe ọnụ iji lụso ọrịa na-efe efe ọgụ. Ụwa sayensị achọpụtala...GỤKWUO -
CPhI & P-MEC China 2019 mere ememe wee nweta nnukwu ihe ịga nke ọma maka ụlọ ọrụ ọgwụ Changzhou!
R&D MANAGEMENT Zuru okè R&D n'elu ikpo okwu wuru Pharmaceutical Research Institute, inwe a post-doctoral resreach mobile ọdụ, na-ejikọta akụrụngwa n'ụzọ zuru ezu, na-eme ka ọganihu mmepe ngwa ngwa.GỤKWUO